Galderma Group AG (GDERF), a Swiss pharmaceutical company specializing in dermatological treatments and skin care products, said on Monday that L'Oréal Groupe plans to acquire an additional 10% stake in the company from Sunshine SwissCo GmbH, a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd.
The transaction will lift L'Oréal's shareholding in Galderma to 20%, building on its initial investment in 2024. The deal is expected to close in the first quarter of 2026.
As part of the increased investment, Galderma said it may nominate two non-independent board candidates from L'Oréal, replacing representatives of the EQT-led consortium.
Galderma also said the companies plan to explore further scientific research collaborations, combining its dermatology expertise with L'Oréal's leadership in the global beauty industry.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.